Please type a search term (at least two characters)
News
World's first primary standard developed for molecular radiotherapy
Researchers from EMRP project develop the world's first primary standard for molecular radiotherapy (MRT) to treat cancer
The new standard will help improve the consistency of MRT treatments, in which radioactive molecules, or radiopharmaceuticals, are injected directly into a patient's body to target and kill cancerous cells. Such standardisation is vital to encourage more widespread use of MRT and develop new and improved radiopharmaceuticals.
Like any form of radiotherapy, the success of MRT relies on the delivery of an extremely precise dose of radiation. The goal is to maximise the dose delivered to the tumour, while minimising damage to surrounding healthy tissue. However, in contrast to other forms of radiotherapy, dosimetry for MRT is not well established. Researchers from EMRP project Metrology for molecular radiotherapy (HLT11 MetroMRT) developed the new standard. A gas-filled ionisation chamber, containing two parallel electrodes an adjustable distance apart, enables the user to measure the absorbed radiation dose from a radioactive solution.
The sources will improve atmospheric transport models which can be used to track both radon and greenhouse gases more
Supporting innovations in combined imaging and radiation cancer treatment by standardising dose measurements more
Between 2009 and 2013 EURAMET funded 119 research projects – many of which continue to benefit European citizens, businesses, and the environment more
Metrology Partnership project is developing the standardised measurements required to protect modern electronics from radio-interference more
FLASH radiotherapy is a new form of cancer treatment promising to minimise damage caused to healthy tissue but requiring metrology for its safe use more